Recent insights on nanomedicine for augmented infection control
Open Access
- 1 April 2019
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 2301-2325
Abstract
Antimicrobial agents have been widely investigated for protecting against microbial infections in modern health. Drug-related limitations, poor bioavailability, toxicity to mammalian cells, and frequent bacteria drug resistance are major challenges faced when exploited in nanomedicine forms. Specific attention has been paid to control nanomaterial-based infection against numerous challenging pathogens in addition to improved drug delivery, targeting, and pharmacokinetic (PK) profiles, and thus, efficient antimicrobials have been fabricated using diverse components (metals, metal oxides, synthetic and semisynthetic polymers, natural or biodegradable polymers, etc). The present review covers several nanocarriers delivered through various routes of administration, highlighting major findings to control microbial infection as compared to using the free drug. Results over the past decade support the consistent development of various nanomedicines capable of improving biological significance and therapeutic benefits against an array of microbial strains. Depending on the intended application of nanomedicine, infection control will be challenged by various factors such as weighing the risk–benefits in healthcare settings, nanomaterial-induced (eco)toxicological hazards, frequent development of antibiotic resistance, scarcity of in vivo toxicity data, and a poor understanding of microbial interactions with nanomedicine at the molecular level. This review summarizes well-established informative data for nanomaterials used for infection control and safety concerns of nanomedicines to healthcare sectors followed by the significance of a unique “safe-by-design” approach.Keywords
This publication has 122 references indexed in Scilit:
- Amphotericin primarily kills yeast by simply binding ergosterolProceedings of the National Academy of Sciences, 2012
- Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acidBiomaterials, 2011
- Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin BInternational Journal of Pharmaceutics, 2011
- Metallic Copper as an Antimicrobial SurfaceApplied and Environmental Microbiology, 2011
- Controlled Release of Biologically Active Silver from Nanosilver SurfacesACS Nano, 2010
- Antibiotics for Emerging PathogensScience, 2009
- Engineering Substrate Topography at the Micro‐ and Nanoscale to Control Cell FunctionAngewandte Chemie International Edition, 2009
- Influence of Surface Properties on the Adhesion of Staphylococcus epidermidis to Acrylic and SiliconeInternational Journal of Biomaterials, 2009
- Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracisBioorganic & Medicinal Chemistry, 2008
- Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006